Evidence map›Paper›PMID 41430759›Full record

ArticleThe Pediatric infectious disease journal2026

The Utility of a Three-gene Host Response to Discriminate Tuberculous Meningitis From Other Infections in Children.

Julie Huynh, Nhat Hoang Thanh Le, Bao Hoai Le Nguyen, Hai Thanh Hoang, Van La Ngoc, Samuel Ensor, Khanh Quoc Nguyen Phan, Ny Hong Thi Tran, Tram Ngoc Pham, Thu Anh Dang Do and 13 more

Abstract read
In one paragraph

Article in The Pediatric infectious disease journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Julie HuynhFrom the Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.ORCID 0000-0002-9247-4267
Nhat Hoang Thanh LeFrom the Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Bao Hoai Le NguyenFrom the Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Hai Thanh HoangFrom the Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Van La NgocFrom the Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Samuel EnsorFrom the Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Khanh Quoc Nguyen PhanFrom the Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Ny Hong Thi TranFrom the Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Tram Ngoc PhamFrom the Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Thu Anh Dang DoFrom the Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Trinh Thi Bich TramFrom the Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Dung Thi Mong VuFrom the Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Vinh Dinh DoFrom the Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Anna GriffithsInstitute of Clinical Trials and Methodology, Medical Research Council Clinical Trials Unit at University College of London, High Holborn, United Kingdom.
Suzanne AndersonInstitute of Clinical Trials and Methodology, Medical Research Council Clinical Trials Unit at University College of London, High Holborn, United Kingdom.
Diana GibbInstitute of Clinical Trials and Methodology, Medical Research Council Clinical Trials Unit at University College of London, High Holborn, United Kingdom.
Dang Minh Thi HaDepartment of Paediatrics, Pham Ngoc Thach Hospital for Tuberculosis and Lung Disease.
Trinh Huu TungDepartment of Infectious Diseases, Children's Hospital 2, Ho Chi Minh City, Vietnam.
Nguyen Dinh QuiDepartment of Infectious Diseases, Children's Hospital 2, Ho Chi Minh City, Vietnam.
Nguyen Hong Thi NhungDepartment of Paediatrics, Pham Ngoc Thach Hospital for Tuberculosis and Lung Disease.
Guy E ThwaitesFrom the Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Nguyen Thuy Thuong ThuongFrom the Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
SURE trial team

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEarly diagnosis of tuberculous meningitis (TBM) is critical to favorable outcomes. We investigated whether a 3-gene host response signature in whole blood can distinguish TBM from symptomatic controls in children.

methodsWhole-blood RNA sequencing was performed in children with TBM and controls. Expression of the 3-gene signature, [guanylate-binding protein (GBP5), dual specificity phosphatase 3 (DUSP3) and Krupple-like factor 2 (KLF2)] was quantified and a tuberculosis (TB) score was calculated using (GBP5+DUSP3)/2-KLF2. Discriminatory performance was obtained using receiver-operator characteristic curve analysis against microbiologic and composite reference standards. TB score and 3-gene expression in children were compared against adults with TBM. In parallel, an exploratory transcriptome-wide analysis was performed, applying bootstrapped least absolute shrinkage and selection operator regression to identify additional genes associated with TBM.

resultsForty-two children had TBM and 41 were controls. KLF2 was upregulated in TBM compared to controls ( P = 0.043); while GBP5, DUSP3 and TB score showed no difference. The diagnostic performance of GBP5 alone (area under the curves: 0.64; 95% confidence interval: 0.46-0.83) and TB score (area under the curves: 0.59; 95% confidence interval: 0.41-0.77) was poor against the reference standard of definite TBM. GBP5 in children with TBM was lower than in adults without HIV (median 13.04; interquartile ranges: 11.91-14.29 vs. median 13.72; interquartile ranges: 12.58-14.53, P = 0.036), and expression was nonlinear across the age spectrum; lowest in young children. Exploratory transcriptomic analysis suggests that novel genes may contribute a discriminatory signal.

conclusionThe 3-gene host response signature does not discriminate TBM from controls in children and was much less discriminative compared to adults. An alternative set of pediatric-specific signatures may exist, but further discovery and validation are required.

Indexed as

Tuberculosis, MeningealAdolescentChildChild, PreschoolDiagnosis, DifferentialFemaleGene Expression ProfilingHumansInfantKruppel-Like Transcription FactorsMaleKLF2 protein, humanKruppel-Like Transcription Factorschilddiagnostictranscriptomictuberculous meningitis

Identifiers

PMID41430759
PMCPMC13064836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.